Therefore, we here developed and evaluated the therapeutic potential of a novel β2-and β3-AR, named ATR-127, for the treatment of obesity and its associated metabolic perturbations in preclinical models. This evidence concerns the gene ADRB3 and obesity due to melanocortin 4 receptor deficiency.